Kim Sablich

Kim Sablich

Nessuna posizione attualmente
57 anni
Health Technology
Consumer Services
Technology Services

Profilo

Kim Sablich formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2021 to 2024, AllerGenis LLC, as Director from 2018 to 2021, GSK Plc, as Vice President from 2015 to 2018, Jazz Pharmaceuticals Plc, as Executive VP & General Manager-North America from 2020 to 2023, Myovant Sciences, Inc., as Chief Commercial Officer from 2018 to 2020, and Myovant Sciences Ltd., as Chief Commercial Officer from 2018 to 2020.
Ms. Sablich received her undergraduate degree from Denison University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Precedenti posizioni note di Kim Sablich

SocietàPosizioneFine
EIGER BIOPHARMACEUTICALS Direttore/Membro del Consiglio 01/09/2024
JAZZ PHARMACEUTICALS PLC Corporate Officer/Principal 31/12/2023
Direttore/Membro del Consiglio 01/04/2021
MYOVANT SCIENCES LTD. Corporate Officer/Principal 11/05/2020
Corporate Officer/Principal 01/05/2020
Vedi nel dettaglio l'esperienza di Kim Sablich

Formazione di Kim Sablich

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Mercati
  2. Insiders
  3. Kim Sablich